Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Buchegger

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patientsFranz Buchegger, Florent Bonvin, Marek Kosinski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2013
First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapyFranz Buchegger, Valentina Garibotto, Thomas Zilli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridineFranz Buchegger, Jean-Marc Vieira, Peter Blaeuenstein, et al.
EJNMMI Research|May 20, 2017
First in-human radiation dosimetry of <sup>68</sup>Ga-NODAGA-RGDyKSilvano Gnesin, Periklis Mitsakis, Francesco Cicone, et al.
Radiation Oncology (London, England)|December 26, 2008
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade gliomaDamien C Weber, Thomas Zilli, Franz Buchegger, et al.
Clinical Nuclear Medicine|February 28, 2017
Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate CancerGiorgio Lamanna, Claire Tabouret-Viaud, Olivier Rager, et al.
Molecular Cancer|April 21, 2011
Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemiaSéverine Loisel, Pierre-Alain André, Josee Golay, et al.
Bioconjugate Chemistry|July 6, 2010
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutantsD Scott Wilbur, Steven I Park, Ming-Kuan Chyan, et al.
Molecular Imaging and Biology|June 18, 2010
Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomographyDavid Viertl, Angelika Bischof Delaloye, Bernard Lanz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphomaSteven I Park, Jaideep Shenoi, Shani M Frayo, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patientsFranz Buchegger, Florent Bonvin, Marek Kosinski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2013
First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapyFranz Buchegger, Valentina Garibotto, Thomas Zilli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridineFranz Buchegger, Jean-Marc Vieira, Peter Blaeuenstein, et al.
EJNMMI Research|May 20, 2017
First in-human radiation dosimetry of <sup>68</sup>Ga-NODAGA-RGDyKSilvano Gnesin, Periklis Mitsakis, Francesco Cicone, et al.
Radiation Oncology (London, England)|December 26, 2008
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade gliomaDamien C Weber, Thomas Zilli, Franz Buchegger, et al.
Clinical Nuclear Medicine|February 28, 2017
Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate CancerGiorgio Lamanna, Claire Tabouret-Viaud, Olivier Rager, et al.
Molecular Cancer|April 21, 2011
Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemiaSéverine Loisel, Pierre-Alain André, Josee Golay, et al.
Bioconjugate Chemistry|July 6, 2010
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutantsD Scott Wilbur, Steven I Park, Ming-Kuan Chyan, et al.
Molecular Imaging and Biology|June 18, 2010
Increase of [(18)F]FLT tumor uptake in vivo mediated by FdUrd: toward improving cell proliferation positron emission tomographyDavid Viertl, Angelika Bischof Delaloye, Bernard Lanz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphomaSteven I Park, Jaideep Shenoi, Shani M Frayo, et al.
Pageof 5